
Conviction is best enjoyed in moderation: the stronger it is, the faster you have to lose it. Charles Harris, portfolio manager at O’Neil Global Advisors, joins Investor’s Business Daily’s “Investing with IBD” podcast to discuss key habits that help rein in your conviction, and the strengths in SharkNinja (SN), Eli Lilly (LLY) and Palantir (PLTR). Chapters: Open & Market Analysis: 0:00 Investing Lessons: 22:30 Stocks To Watch: 44:42 New to trading? Check out our daily newsletter! https://get.investors.com/marketdiem/ Get more IBD by subscribing to our channel: https://www.youtube.com/@investorsbusinessdaily Visit our website: https://www.investors.com Like us on Facebook: https://www.facebook.com/investorsbusinessdaily Follow us on Twitter: https://twitter.com/IBDinvestors Follow us on Instagram: https://www.instagram.com/investorsbusinessdaily/ Follow us on StockTwits: https://stocktwits.com/InvestorsBusinessdaily Follow us on LinkedIn: https://www.linkedin.com/company/investors-business-daily Follow us on TikTok: https://www.tiktok.com/@ibdinvestors Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market. #InvestorsBusinessDaily #IBD #InvestingWithIBD #Podcast

Charles Harris On How To Handle Concentrated Positions With Conviction | Investing With IBD

What Tesla Stock Taught Charles Harris About Trading | Investing with IBD

Charles Harris: It’s About More Than Just The Money | Investing with IBD

Remembering Bill O'Neil: Honoring The Life And Legacy Of IBD's Founder | IBD Live

Charles Harris: Playbook For The Next Raging Bull & For Today | Trader Tales With IBD | Alissa Coram

The Pros And Cons Of Secondary Indicators | Investing With IBD

Charles Harris: It’s About More Than Just The Money | Investing with IBD

How This Week Changed Our Outlook; Ferrari, Costco, DaVita In Focus | Stock Market Today

Handling Tesla, SMCI And Portfolio Exposure With Fed Rate Cuts In Debate | Investing With IBD

Why Minervini Calls Volatility A Rare Moment For This Market | Investing With IBD

Mark Minervini: Is The Party Over Or Just Getting Started? | Investing With IBD Podcast

This Is The Most Important Question About AI And Microsoft May Have The Answer | Investing With IBD